Clinical Trials Browser

Phase 1/2 × Completed × Pathologic Complete Response × Clear all

NCT02789254 2023-12-28

FLYSYN-101

Phase 1/2 Completed

Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Leukemia, Myeloid, Acute